Product range and specialization Metabolic peptides offered: Beyond retatrutide, Paradigm Peptides stocks semaglutide, tirzepatide, and other weight loss peptides for comparative research
Matthias Tschp and Richard DiMarchi developed the first dual and triple agonist weight loss drugs
"If India is starting to manufacture GLP-1s at a large scale, that will not all stay in India, whatever companies try, countries try to prevent it from coming in," Ben van der Schaaf, Partner at Arthur D
Without stronger enforcement at our borders, inspections of compounding facilities, and accountability for companies that break the law, unsafe products will continue reaching patients
Henry Meds is known for simplicity and low-cost access, offering compounded semaglutide injections from $297/month and oral options from $249/month
Dual agonists cost more and may cause slightly more side effects